Compounds > 3,4-methylenedioxyamphetamine
Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Heart Valve Diseases

3,4-methylenedioxyamphetamine has been researched along with Heart Valve Diseases in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Setola, V1
Hufeisen, SJ1
Grande-Allen, KJ1
Vesely, I1
Glennon, RA1
Blough, B1
Rothman, RB1
Roth, BL1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Heart Valve Diseases

ArticleYear
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
    Molecular pharmacology, 2003, Volume: 63, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Cell Division; Cells, Cultured; COS Cells; Fenfluramine; Hea

2003